Clay-Based Pharmaceutical Formulations and Drug Delivery Systems
This book includes recent advances in the use of clays in the design of medicinal products and medicinal devices. The pharmaceutical applications of nanoclays are far ranging, because of their distinct advantages: they are versatile (possess a wide range of mechanical, chemical and physical properti...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2021 |
Language: | English |
Physical Description: | 1 electronic resource (202 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545151804498 |
---|---|
ctrlnum |
(CKB)5400000000040756 (oapen)https://directory.doabooks.org/handle/20.500.12854/68311 (EXLCZ)995400000000040756 |
collection |
bib_alma |
record_format |
marc |
spelling |
Viseras, César edt Clay-Based Pharmaceutical Formulations and Drug Delivery Systems Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021 1 electronic resource (202 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier This book includes recent advances in the use of clays in the design of medicinal products and medicinal devices. The pharmaceutical applications of nanoclays are far ranging, because of their distinct advantages: they are versatile (possess a wide range of mechanical, chemical and physical properties) and available at reasonable costs. Some special clays (mainly kaolinite, halloysite, montmorillonite, saponite, hectorite, palygorskite and sepiolite), as well as semi-synthetic (organoclays) or synthetic (double layer hydroxides) derivatives, are very useful materials for modulating drug delivery. In the last decade, several actives have been loaded onto nanoclays and similar inorganic excipients to increase solubility, improve stability, reduce toxicity, and enhance bioavailability, with a consequent increase in therapeutic response. Polymer/clay nanocomposites with synergic properties have been developed, showing improved mechanical properties with respect to the pristine polymer matrices and allowing modified release of loaded actives. Moreover, nanoclays have very recently demonstrated positive effects on the proliferation and migration of fibroblasts. The development of clay-based medicinal products and medicinal devices requires experience in the fields of both clay structure and properties and pharmaceutical technology design. English Medicine bicssc hydrochlorothiazide cyclodextrins sepiolite nanoclay dissolution rate tablet electrospinning chitosan chondroitin sulfate scaffolds montmorillonite halloysite fibroblasts proliferation immune response glycosaminoglycans antimicrobial properties palygorskite spring water hydrogel fibroblast biocompatibility wound healing mesoporous clay Neusilin aeroperl liquisolid technique glyburide dissolution improvement hydrotalcite ketoprofen hybrid photostability hydrogel film bioadhesion heavy metal hazardous element element mobility clay minerals toxicity palygorksite proliferation Franz cell bioactive elements praziquantel drug organic solvents in vitro dissolution tests cytotoxicity targeted drug delivery halloysite nanotube osteosarcoma methotrexate surface modification 3-0365-0186-X 3-0365-0187-8 Viseras, César oth |
language |
English |
format |
eBook |
author2 |
Viseras, César |
author_facet |
Viseras, César |
author2_variant |
c v cv |
author2_role |
Sonstige |
title |
Clay-Based Pharmaceutical Formulations and Drug Delivery Systems |
spellingShingle |
Clay-Based Pharmaceutical Formulations and Drug Delivery Systems |
title_full |
Clay-Based Pharmaceutical Formulations and Drug Delivery Systems |
title_fullStr |
Clay-Based Pharmaceutical Formulations and Drug Delivery Systems |
title_full_unstemmed |
Clay-Based Pharmaceutical Formulations and Drug Delivery Systems |
title_auth |
Clay-Based Pharmaceutical Formulations and Drug Delivery Systems |
title_new |
Clay-Based Pharmaceutical Formulations and Drug Delivery Systems |
title_sort |
clay-based pharmaceutical formulations and drug delivery systems |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2021 |
physical |
1 electronic resource (202 p.) |
isbn |
3-0365-0186-X 3-0365-0187-8 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT viserascesar claybasedpharmaceuticalformulationsanddrugdeliverysystems |
status_str |
n |
ids_txt_mv |
(CKB)5400000000040756 (oapen)https://directory.doabooks.org/handle/20.500.12854/68311 (EXLCZ)995400000000040756 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Clay-Based Pharmaceutical Formulations and Drug Delivery Systems |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796652254813487104 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03903nam-a2200925z--4500</leader><controlfield tag="001">993545151804498</controlfield><controlfield tag="005">20231214133245.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040756</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68311</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040756</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Viseras, César</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clay-Based Pharmaceutical Formulations and Drug Delivery Systems</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (202 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book includes recent advances in the use of clays in the design of medicinal products and medicinal devices. The pharmaceutical applications of nanoclays are far ranging, because of their distinct advantages: they are versatile (possess a wide range of mechanical, chemical and physical properties) and available at reasonable costs. Some special clays (mainly kaolinite, halloysite, montmorillonite, saponite, hectorite, palygorskite and sepiolite), as well as semi-synthetic (organoclays) or synthetic (double layer hydroxides) derivatives, are very useful materials for modulating drug delivery. In the last decade, several actives have been loaded onto nanoclays and similar inorganic excipients to increase solubility, improve stability, reduce toxicity, and enhance bioavailability, with a consequent increase in therapeutic response. Polymer/clay nanocomposites with synergic properties have been developed, showing improved mechanical properties with respect to the pristine polymer matrices and allowing modified release of loaded actives. Moreover, nanoclays have very recently demonstrated positive effects on the proliferation and migration of fibroblasts. The development of clay-based medicinal products and medicinal devices requires experience in the fields of both clay structure and properties and pharmaceutical technology design.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrochlorothiazide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cyclodextrins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sepiolite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nanoclay</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dissolution rate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tablet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">electrospinning</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chitosan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chondroitin sulfate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">scaffolds</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">montmorillonite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">halloysite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fibroblasts proliferation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune response</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glycosaminoglycans</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antimicrobial properties</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">palygorskite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">spring water</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fibroblast</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biocompatibility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">wound healing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mesoporous clay</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Neusilin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aeroperl</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquisolid technique</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glyburide</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dissolution improvement</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrotalcite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ketoprofen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hybrid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">photostability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hydrogel film</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioadhesion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heavy metal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hazardous element</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">element mobility</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clay minerals</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">toxicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">palygorksite</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proliferation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Franz cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioactive elements</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">praziquantel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">organic solvents</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">in vitro dissolution tests</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytotoxicity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">targeted drug delivery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">halloysite nanotube</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">osteosarcoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">methotrexate</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">surface modification</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-0186-X</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-0187-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Viseras, César</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:48:07 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337868060004498&Force_direct=true</subfield><subfield code="Z">5337868060004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337868060004498</subfield></datafield></record></collection> |